With the analysis among 78 patents, we discovered top 13 key players by total patent application. Epizyme, Inc., Abraxis BioScience LLC, Boehringer Ingelheim International GmbH are dominant in this area. They take 62.82% of the total patent filing.
Massachusetts, United States
Patent: 26
California, United States
Patent: 11
Boehringer Ingelheim International GmbH
Rheinland-Pfalz, Germany
Patent: 4
Kymera Therapeutics, Inc.
Massachusetts, United States
Patent: 1
Shanghai Junshi Biosciences Co., Ltd.
Shanghai Shi, China
Patent: 1
Aurigene Discovery Technologies Ltd.
Karnataka, India
Patent: 1
National Cancer Center Korea
Gyeonggi-do, South Korea
Patent: 1
Yonsei Industry-Academic Cooperation Foundation
Ewha University-Industry Collaboration Foundation
No data, please try another search term
With the analysis among related 81 patents applied in the last 5 years. We discover 19 most active companies in this area. The fast-growing Epizyme, Inc., Dana-Farber Cancer Institute, Inc., Abraxis BioScience LLC take 60.49% of patent filing during this period.
Massachusetts, United States
Patent: 26
Dana-Farber Cancer Institute, Inc.
Massachusetts, United States
Patent: 12
California, United States
Patent: 11
Boehringer Ingelheim International GmbH
Rheinland-Pfalz, Germany
Patent: 4
Ningbo Aita Gene Technology Co., Ltd.
Zhejiang Sheng, China
Patent: 1
Nanjing Sino-Australian Institute of Translational Medicine Co., Ltd.
Jiangsu Sheng, China
Patent: 1
Michigan, United States
Patent: 1
Zhongshan Hospital Fudan University
Shanghai Shi, China
Patent: 1
Shanghai Junshi Biosciences Co., Ltd.
Shanghai Shi, China
Patent: 1
Kymera Therapeutics, Inc.
Massachusetts, United States
Patent: 1
With the analysis among related 81 patents in last 5 years, we discover 19 new entrants. Epizyme, Inc., Dana-Farber Cancer Institute, Inc., Abraxis BioScience LLC are the most active new entrants in this area.
Massachusetts, United States
Patent: 26
Dana-Farber Cancer Institute, Inc.
Massachusetts, United States
Patent: 12
California, United States
Patent: 11
Boehringer Ingelheim International GmbH
Rheinland-Pfalz, Germany
Patent: 4
Ningbo Aita Gene Technology Co., Ltd.
Zhejiang Sheng, China
Patent: 1
Nanjing Sino-Australian Institute of Translational Medicine Co., Ltd.
Jiangsu Sheng, China
Patent: 1
Michigan, United States
Patent: 1
Zhongshan Hospital Fudan University
Shanghai Shi, China
Patent: 1
Shanghai Junshi Biosciences Co., Ltd.
Shanghai Shi, China
Patent: 1
Kymera Therapeutics, Inc.
Massachusetts, United States
Patent: 1
No data, please try another search term